Cargando…

Barriers to discontinuing antidepressants in patients with depressive and anxiety disorders: a review of the literature and clinical recommendations

Use of antidepressants has recently increased, mainly caused by the increase of long-term users. Although evidence-based indications for long-term use are lacking, it is assumed that long-term use is unnecessary or undesirable in some patients. Perceived barriers to discontinuing antidepressants con...

Descripción completa

Detalles Bibliográficos
Autores principales: Scholten, Willemijn, Batelaan, Neeltje, Van Balkom, Anton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290254/
https://www.ncbi.nlm.nih.gov/pubmed/32577215
http://dx.doi.org/10.1177/2045125320933404
_version_ 1783545633021362176
author Scholten, Willemijn
Batelaan, Neeltje
Van Balkom, Anton
author_facet Scholten, Willemijn
Batelaan, Neeltje
Van Balkom, Anton
author_sort Scholten, Willemijn
collection PubMed
description Use of antidepressants has recently increased, mainly caused by the increase of long-term users. Although evidence-based indications for long-term use are lacking, it is assumed that long-term use is unnecessary or undesirable in some patients. Perceived barriers to discontinuing antidepressants contribute to unnecessary or undesirable long-term use. Identifying barriers prior to, during and following discontinuation may enable strategies to overcome them. This narrative review summarises relevant qualitative and quantitative articles on perceived barriers to discontinuing antidepressants and provides recommendations for clinical practice. We can conclude that implications for clinical practice are diverse and the most important barriers experienced by patients and physicians include the fear of relapse or recurrence, insufficient evaluation and monitoring, withdrawal symptoms, and actual relapse or recurrence.
format Online
Article
Text
id pubmed-7290254
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-72902542020-06-22 Barriers to discontinuing antidepressants in patients with depressive and anxiety disorders: a review of the literature and clinical recommendations Scholten, Willemijn Batelaan, Neeltje Van Balkom, Anton Ther Adv Psychopharmacol Discontinuing Psychotropic Medications Use of antidepressants has recently increased, mainly caused by the increase of long-term users. Although evidence-based indications for long-term use are lacking, it is assumed that long-term use is unnecessary or undesirable in some patients. Perceived barriers to discontinuing antidepressants contribute to unnecessary or undesirable long-term use. Identifying barriers prior to, during and following discontinuation may enable strategies to overcome them. This narrative review summarises relevant qualitative and quantitative articles on perceived barriers to discontinuing antidepressants and provides recommendations for clinical practice. We can conclude that implications for clinical practice are diverse and the most important barriers experienced by patients and physicians include the fear of relapse or recurrence, insufficient evaluation and monitoring, withdrawal symptoms, and actual relapse or recurrence. SAGE Publications 2020-06-10 /pmc/articles/PMC7290254/ /pubmed/32577215 http://dx.doi.org/10.1177/2045125320933404 Text en © The Author(s), 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Discontinuing Psychotropic Medications
Scholten, Willemijn
Batelaan, Neeltje
Van Balkom, Anton
Barriers to discontinuing antidepressants in patients with depressive and anxiety disorders: a review of the literature and clinical recommendations
title Barriers to discontinuing antidepressants in patients with depressive and anxiety disorders: a review of the literature and clinical recommendations
title_full Barriers to discontinuing antidepressants in patients with depressive and anxiety disorders: a review of the literature and clinical recommendations
title_fullStr Barriers to discontinuing antidepressants in patients with depressive and anxiety disorders: a review of the literature and clinical recommendations
title_full_unstemmed Barriers to discontinuing antidepressants in patients with depressive and anxiety disorders: a review of the literature and clinical recommendations
title_short Barriers to discontinuing antidepressants in patients with depressive and anxiety disorders: a review of the literature and clinical recommendations
title_sort barriers to discontinuing antidepressants in patients with depressive and anxiety disorders: a review of the literature and clinical recommendations
topic Discontinuing Psychotropic Medications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290254/
https://www.ncbi.nlm.nih.gov/pubmed/32577215
http://dx.doi.org/10.1177/2045125320933404
work_keys_str_mv AT scholtenwillemijn barrierstodiscontinuingantidepressantsinpatientswithdepressiveandanxietydisordersareviewoftheliteratureandclinicalrecommendations
AT batelaanneeltje barrierstodiscontinuingantidepressantsinpatientswithdepressiveandanxietydisordersareviewoftheliteratureandclinicalrecommendations
AT vanbalkomanton barrierstodiscontinuingantidepressantsinpatientswithdepressiveandanxietydisordersareviewoftheliteratureandclinicalrecommendations